332 related articles for article (PubMed ID: 10096833)
1. Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity.
Lacroix PM; Dawson BA; Sears RW; Black DB; Cyr TD; Ethier JC
J Pharm Biomed Anal; 1998 Nov; 18(3):383-402. PubMed ID: 10096833
[TBL] [Abstract][Full Text] [Related]
2. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
[TBL] [Abstract][Full Text] [Related]
3. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
[TBL] [Abstract][Full Text] [Related]
4. Impurity profiling of carbocisteine by HPLC-CAD, qNMR and UV/vis spectroscopy.
Wahl O; Holzgrabe U
J Pharm Biomed Anal; 2014 Jul; 95():1-10. PubMed ID: 24637049
[TBL] [Abstract][Full Text] [Related]
5. Impurity assessment, development and validation of an RP-HPLC method for the determination of eleven potential impurities of eltrombopag precursor.
Demirhan T; Guksu E; Yazar Y; Keskin E; Bellur Atici E; Özkan SA
J Pharm Biomed Anal; 2024 Jun; 243():116085. PubMed ID: 38471254
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatographic determination of pindolol and related compounds in raw materials.
Lacroix PM; Moir D; Lovering EG
J Assoc Off Anal Chem; 1990; 73(4):521-5. PubMed ID: 2211472
[TBL] [Abstract][Full Text] [Related]
7. LC determination of glimepiride and its related impurities.
Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
[TBL] [Abstract][Full Text] [Related]
8. Validation of a reversed-phase HPLC method for 1,10-phenanthroline-5,6-dione and analysis of its impurities by HPLC-MS.
Shabir GA; Forrow NJ
J Pharm Biomed Anal; 2003 Sep; 33(2):219-30. PubMed ID: 12972087
[TBL] [Abstract][Full Text] [Related]
9. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
[TBL] [Abstract][Full Text] [Related]
10. Identification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds.
Zhang H; Sun L; Zou L; Hui W; Liu L; Zou Q; Ouyang P
J Pharm Biomed Anal; 2016 Sep; 128():18-27. PubMed ID: 27209451
[TBL] [Abstract][Full Text] [Related]
11. Stability-Indicating RP-HPLC Method for the Estimation of Process-Related Impurities and Degradation Products in Fesoterodine Fumarate by Using a Mass Spectrometric Compatible Mobile Phase.
Kumar N; Sangeetha D; Kalyanraman L
J Chromatogr Sci; 2021 Jan; 59(2):154-164. PubMed ID: 33190158
[TBL] [Abstract][Full Text] [Related]
12. [Separation and identification of impurities from intermediates of istradefylline].
Wang Y; Lü X; Xu H; Meng Z; Li J; Xu Z; Xue M
Se Pu; 2021 Apr; 39(4):430-436. PubMed ID: 34227764
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC.
Rajana N; Devi DR; Kumar Reddy DN; Babu JM; Basavaiah K; Balakumaran K
J Chromatogr Sci; 2020 Apr; 58(5):433-444. PubMed ID: 32134104
[TBL] [Abstract][Full Text] [Related]
14. A Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Ibrutinib Using QbD Approach by RP-HPLC, NMR Spectroscopy and ESI-MS.
Gopireddy RR; Maruthapillai A; Mahapatra S
J Chromatogr Sci; 2021 Sep; 59(9):830-846. PubMed ID: 33420506
[TBL] [Abstract][Full Text] [Related]
15. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
[TBL] [Abstract][Full Text] [Related]
16. Characterization of unknown impurities in Coenzyme Q
Deng Y; Chen X; Wang L; Peng X; Lin M
J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
[TBL] [Abstract][Full Text] [Related]
17. High-pressure liquid chromatographic methods for ciprofloxacin hydrochloride and related compounds in raw materials.
Lacroix PM; Curran NM; Sears RW
J Pharm Biomed Anal; 1996 Mar; 14(5):641-54. PubMed ID: 8738195
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
19. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
20. [Determination of unknown impurities in cefotiam hexetil by HPLC-MS/MS].
Tang QX; Liu MD; Yan YY; Ye Y; Wang ZH; Zhan LF; Liao LC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 May; 44(3):481-4, 493. PubMed ID: 23898540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
